awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40446321-36F4ADE7-2177-4E80-AAA1-786593BC96C8
Q40446321-36F4ADE7-2177-4E80-AAA1-786593BC96C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40446321-36F4ADE7-2177-4E80-AAA1-786593BC96C8
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
P2860
Q40446321-36F4ADE7-2177-4E80-AAA1-786593BC96C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40446321-36F4ADE7-2177-4E80-AAA1-786593BC96C8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
937a993d56f06bda09b2f008869d62045552a448
P2860
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.